VXRT vs. LRN
VXRT (Vaxart, Inc.) and LRN (Stride, Inc.) are both stocks. VXRT operates in Biotechnology (Healthcare), while LRN operates in Education & Training Services (Consumer Defensive). Over the past 5 years, VXRT returned -40.93%/yr vs 22.60%/yr for LRN. At a 0.13 correlation, their price movements are largely independent.
Performance
VXRT vs. LRN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VXRT achieves a 48.63% return, which is significantly higher than LRN's 34.95% return.
VXRT
- 1D
- -2.86%
- 1M
- -8.47%
- 6M
- -20.79%
- YTD
- 48.63%
- 1Y
- 29.59%
- 3Y*
- -12.22%
- 5Y*
- -40.93%
- 10Y*
- —
LRN
- 1D
- 5.07%
- 1M
- 5.11%
- 6M
- 25.55%
- YTD
- 34.95%
- 1Y
- -34.17%
- 3Y*
- 32.85%
- 5Y*
- 22.60%
- 10Y*
- 20.64%
VXRT vs. LRN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
VXRT Vaxart, Inc. | 48.63% | -47.68% | 15.59% | -40.39% | -84.67% | 9.81% | 1,529.10% | -81.36% | -78.09% |
LRN Stride, Inc. | 34.95% | -37.53% | 75.05% | 89.80% | -6.15% | 56.99% | 4.32% | -17.91% | 59.83% |
Correlation
The correlation between VXRT and LRN is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Feb 12, 2018 | 0.13 |
The correlation between VXRT and LRN shifts across timeframes, from 0.07 (1 year) to 0.17 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
VXRT:
$124.62M
LRN:
$3.73B
VXRT:
$0.16
LRN:
$9.77
VXRT:
3.25
LRN:
8.97
VXRT:
0.01
LRN:
0.22
VXRT:
0.47
LRN:
1.66
VXRT:
1.32
LRN:
2.54
VXRT:
$255.61M
LRN:
$2.54B
VXRT:
$193.63M
LRN:
$972.24M
VXRT:
$45.63M
LRN:
$424.60M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VXRT vs. LRN — Risk / Return Rank
VXRT
LRN
VXRT vs. LRN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vaxart, Inc. (VXRT) and Stride, Inc. (LRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VXRT | LRN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.84 | ||
| Sortino ratioReturn per unit of downside risk | +1.37 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 0.96 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 0.81 | -0.54 | +1.35 |
| Martin ratioReturn relative to average drawdown | 1.56 | -0.77 | +2.33 |
Loading charts...
Drawdowns
VXRT vs. LRN - Drawdown Comparison
The maximum VXRT drawdown since its inception was -98.71%, which is greater than LRN's maximum drawdown of -81.41%. Use the drawdown chart below to compare losses from any high point for VXRT and LRN.
Loading charts...
Drawdown Indicators
| VXRT | LRN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.71% | -81.41% | -17.30% |
Max Drawdown (1Y)Largest decline over 1 year | -36.62% | -64.07% | +27.45% |
Max Drawdown (3Y)Largest decline over 3 years | -78.72% | -64.07% | -14.65% |
Max Drawdown (5Y)Largest decline over 5 years | -96.94% | -64.07% | -32.87% |
Max Drawdown (10Y)Largest decline over 10 years | — | -64.07% | — |
Current DrawdownCurrent decline from peak | -97.79% | -48.40% | -49.39% |
Average DrawdownAverage peak-to-trough decline | -83.09% | -36.33% | -46.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 19.02% | 44.40% | -25.38% |
Volatility
VXRT vs. LRN - Volatility Comparison
Vaxart, Inc. (VXRT) has a higher volatility of 18.75% compared to Stride, Inc. (LRN) at 10.49%. This indicates that VXRT's price experiences larger fluctuations and is considered to be riskier than LRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VXRT | LRN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 18.75% | 10.49% | +8.26% |
Volatility (6M)Calculated over the trailing 6-month period | 51.79% | 29.96% | +21.83% |
Volatility (1Y)Calculated over the trailing 1-year period | 87.70% | 68.79% | +18.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 92.44% | 51.51% | +40.93% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 128.14% | 49.40% | +78.74% |
Dividends
VXRT vs. LRN - Dividend Comparison
Neither VXRT nor LRN has paid dividends to shareholders.
Financials
VXRT vs. LRN - Financials Comparison
This section allows you to compare key financial metrics between Vaxart, Inc. and Stride, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VXRT vs. LRN - Profitability Comparison
VXRT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Vaxart, Inc. reported a gross profit of 0.00 and revenue of 39.23M. Therefore, the gross margin over that period was 0.0%.
LRN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Stride, Inc. reported a gross profit of 231.56M and revenue of 629.87M. Therefore, the gross margin over that period was 36.8%.
VXRT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Vaxart, Inc. reported an operating income of 5.17M and revenue of 39.23M, resulting in an operating margin of 13.2%.
LRN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Stride, Inc. reported an operating income of 129.08M and revenue of 629.87M, resulting in an operating margin of 20.5%.
VXRT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Vaxart, Inc. reported a net income of 5.18M and revenue of 39.23M, resulting in a net margin of 13.2%.
LRN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Stride, Inc. reported a net income of 248.49M and revenue of 629.87M, resulting in a net margin of 39.5%.
Frequently Asked Questions
VXRT and LRN have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VXRT has higher volatility (18.75%) compared to LRN (10.49%). In terms of maximum drawdown, VXRT dropped -98.71% vs LRN's -81.41%.
VXRT currently has the higher Sharpe Ratio (0.34 vs -0.50), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VXRT and LRN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer